BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22871364)

  • 1. [Interstitial pneumonitis due to gemcitabine].
    San José Ruiz B; Molas Ferrer G; Castro Rebollo P; Soy Muner D
    Farm Hosp; 2012; 36(5):452-3. PubMed ID: 22871364
    [No Abstract]   [Full Text] [Related]  

  • 2. Side effects of chemotherapy. Case 3. Acute interstitial pneumonitis related to gemcitabine.
    Attar EC; Ervin T; Janicek M; Deykin A; Godleski J
    J Clin Oncol; 2000 Feb; 18(3):697-8. PubMed ID: 10653887
    [No Abstract]   [Full Text] [Related]  

  • 3. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of drug-induced interstitial pneumonitis after adjuvant chemotherapy with gemcitabine for bile duct cancer].
    Mori R; Misuta K; Sasaki M; Murakami T; Tokuhisa M; Hasegawa S; Eguchi K; Nakano A
    Gan To Kagaku Ryoho; 2010 May; 37(5):923-6. PubMed ID: 20495330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe pulmonary toxicity in a patient treated with gemcitabine.
    Rosado MF; Kett DH; Schein RM; Baraona FJ; Sridhar KS
    Am J Clin Oncol; 2002 Feb; 25(1):31-3. PubMed ID: 11823691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety profiles of gemcitabine hydrochloride(GEMZAR®)in Japanese clinical studies].
    Ishii M; Nagaoka S; Tatsumi M; Kitagawa N; Taketsuna M; Okubo S; Maeda K; Takeuchi K
    Gan To Kagaku Ryoho; 2011 Dec; 38(13):2607-16. PubMed ID: 22189227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of drug-induced interstitial pneumonitis after gemcitabine treatment for advanced pancreatic cancer].
    Nomura M; Inoue Y; Fujita S; Sakao J; Hirota M; Souda S
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):123-7. PubMed ID: 16410712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine-induced pulmonary toxicity: case report and review of the literature.
    Gupta N; Ahmed I; Steinberg H; Patel D; Nissel-Horowitz S; Mehrotra B
    Am J Clin Oncol; 2002 Feb; 25(1):96-100. PubMed ID: 11823707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of interstitial pneumonia induced by gemcitabine hydrochloride for unresectable bile duct cancer].
    Miura T; Suzuki N; Ozeki Y; Nakamura J; Yamada S; Miura T; Yanagi M; Sato K; Takahashi T
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1757-60. PubMed ID: 19838043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
    Pavlakis N; Bell DR; Millward MJ; Levi JA
    Cancer; 1997 Jul; 80(2):286-91. PubMed ID: 9217042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine pulmonary toxicity: CT features.
    Boiselle PM; Morrin MM; Huberman MS
    J Comput Assist Tomogr; 2000; 24(6):977-80. PubMed ID: 11105721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma.
    Galvão FH; Pestana JO; Capelozzi VL
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):607-10. PubMed ID: 19904536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of interstitial pneumonia during gemcitabine and cisplatin chemotherapy for locally advanced bladder cancer].
    Matsumura E; Ashikari A; Tasaki S; Haranaga S; Toyosato T; Ashimine S; Machida N; Oshiro Y; Saito S
    Hinyokika Kiyo; 2011 Feb; 57(2):81-5. PubMed ID: 21412040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-associated B-cell lymphoproliferative disorder in a patient with Sézary syndrome treated by methotrexate.
    Ingen-Housz-Oro S; Ortonne N; Cordel N; Moroch J; Do-Pham G; Delfau MH; Haioun C; Chosidow O
    Br J Dermatol; 2016 Aug; 175(2):430-3. PubMed ID: 27031298
    [No Abstract]   [Full Text] [Related]  

  • 15. Erysipeloid skin toxicity induced by gemcitabine.
    Zustovich F; Pavei P; Cartei G
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):757-8. PubMed ID: 16836522
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interstitial lung disease in a patient given gemcitabine].
    Hammerer V; Schmitz N; Pauli G; Quoix E
    Rev Pneumol Clin; 2002 Feb; 58(1):23-6. PubMed ID: 11981501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine and vascular toxicity.
    Muñoz A; Mañé JM; Rubio I; Fernández R; Fuente N; Barceló R; López Vivanco G
    Lung Cancer; 2002 Aug; 37(2):229. PubMed ID: 12140148
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemolytic-uremic syndrome caused by gemcitabine.
    Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
    Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
    [No Abstract]   [Full Text] [Related]  

  • 19. Gemcitabine and haemolytic-uraemic syndrome.
    Ruiz I; Del Valle J; Gómez A
    Ann Oncol; 2004 Oct; 15(10):1575-6. PubMed ID: 15367421
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal pulmonary toxicity resulting from treatment with gemcitabine.
    Tempero MA; Brand R
    Cancer; 1998 May; 82(9):1800-1. PubMed ID: 9576306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.